The grant seeks to enhance cancer research by using advanced molecular imaging to gain insights into inflammation dynamics in vivo.
Grants for cancer research projects using imaging and liquid biopsies to monitor therapy responses and resistance emergence in patients.
This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.
The National Cancer Institute funds early-stage proof-of-concept studies of innovative technologies for cancer characterization or biospecimen handling and quality control; clinical trials are not allowed.
This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.
This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.